United States · FDA National Drug Code directory
BEVESPI AEROSPHERE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0310-4600_90a24746-75fb-490b-9e0d-7e33a5d8f00a
- Product NDC
- 0310-4600
- Form
- AEROSOL, METERED
- Composition / generic term
- Glycopyrrolate and formoterol fumarate
- Labeler
- AstraZeneca Pharmaceuticals LP
- Marketing category
- NDA
- Marketing start / end (source format)
- 20161003
- Source listing expiry
- 20261231
Source-listed ingredients
- GLYCOPYRROLATE — 9 ug/1
- FORMOTEROL FUMARATE — 4.8 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 120 AEROSOL, METERED in 1 INHALER (0310-4600-12) · 0310-4600-12
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →